A leading coronavirus vaccine candidate just started human trials in the US. Pfizer’s chief scientist told us how it could be ready for emergency use this fall.

"I don't think this has ever happened in the history of modern vaccines," Pfizer Chief Scientific Officer Mikael Dolsten told Business Insider.